Senior Manager, Contracts
Intellia Therapeutics, Inc.
Summary
We are seeking a Senior Manager of Contracts to join our Legal team. This individual will serve as a key operational and strategic partner for contract drafting, negotiation, execution, and lifecycle management across the company. The ideal candidate is a proactive, highly organized self-starter who thrives in a fast-paced biotech environment and can confidently manage competing priorities.
Job description
This role will own the end-to-end contract lifecycle — from intake and drafting through negotiation, execution, and CLM administration — and will serve as a primary point of contact for internal stakeholders across departments including Research, Clinical, Commercial and G&A.
Responsibilities
- Draft, review, and negotiate a wide variety of contracts, including but not limited to confidentiality agreements (CDAs/NDAs), master service agreements (MSAs), statements of work (SOWs), consulting agreements, vendor and supplier agreements, and other commercial contracts.
- Partner directly with internal stakeholders across departments to understand project scopes, objectives, and risk tolerance; translate stakeholder needs into clear, enforceable contract language.
- Identify and flag legal, regulatory, and business risks in contract terms; escalate issues appropriately to senior legal counsel.
- Serve as a subject matter expert and administrator for the CLM (Ironclad) platform, including managing templates, workflows, user permissions, reporting, and system enhancements; troubleshoot issues and support user training as needed.
- Manage and continuously improve contracting workflows, processes, reporting, and metrics to drive efficiency, consistency, and scalability.
- Identify opportunities for automation, process enhancement, and operational improvements across the contract lifecycle.
- Support ad hoc legal and cross-functional projects as needed.
About You
- Exceptional organizational and time-management skills, with the ability to manage a high volume of contracts and competing deadlines simultaneously.
- Self-motivated, driven, and comfortable working independently with minimal supervision.
- Strong business acumen and the ability to build trusted relationships with stakeholders across all levels and departments.
- Excellent written and verbal communication skills, with the ability to explain contract terms and risks in clear, business-friendly language.
- High attention to detail and strong analytical and problem-solving skills.
- Bachelor's degree required; paralegal certificate, JD, or relevant advanced degree a plus (not required).
- 7+ years of experience in contract management, contract negotiation, or a related legal/commercial function, ideally within the biotech, pharmaceutical, or life sciences industry.
- Hands-on experience administering a Contract Lifecycle Management (CLM); experience configuring workflows, templates, or reporting is a strong plus.
- Prolonged periods of sitting at a desk and working on a computer.
Requirements
- Bachelor's degree required
- 7+ years of experience in contract management, contract negotiation, or a related legal/commercial function
- Experience ideally within the biotech, pharmaceutical, or life sciences industry
- Hands-on experience administering a Contract Lifecycle Management (CLM)
- Exceptional organizational and time-management skills
- Self-motivated and comfortable working independently
- Strong business acumen and relationship-building skills
- Excellent written and verbal communication skills
- High attention to detail and strong analytical and problem-solving skills
Benefits
- Performance-based annual cash bonus
- New hire equity grant
- Annual equity awards
- Health benefits
Company overview
Intellia Therapeutics, Inc. is a leading clinical-stage biotechnology company focused on revolutionizing medicine through CRISPR-based gene editing therapies. Founded in 2014 and headquartered in Cambridge, Massachusetts, the company leverages Nobel Prize-winning CRISPR/Cas9 technology to develop potentially curative treatments for severe genetic diseases. Intellia operates with a dual approach: in vivo programs that use intravenously administered CRISPR to edit disease-causing genes directly within the body, and ex vivo programs that engineer human cells outside the body to treat cancer and autoimmune diseases. The company's pipeline includes advanced clinical programs for hereditary angioedema (NTLA-2002) and transthyretin amyloidosis (NTLA-2001), both in late-stage clinical trials. Intellia has established strategic collaborations with major pharmaceutical companies including Regeneron and Novartis, and maintains a strong intellectual property portfolio with over 400 patent documents. As a publicly traded company (NASDAQ: NTLA) with approximately 500-1,000 employees, Intellia represents a pioneering force in the gene editing space, working to transform the treatment paradigm for patients with serious genetic disorders through one-time, potentially curative therapies.